Hazen A L, Walker J R, Eldridge G D
Anxiety Disorders Research Program, St. Boniface General Hospital, Winnipeg, Canada.
Anxiety. 1996;2(1):34-9. doi: 10.1002/(SICI)1522-7154(1996)2:1<34::AID-ANXI5>3.0.CO;2-D.
The purpose of this study was to examine the relationship between change in anxiety sensitivity, as measured by the Anxiety Sensitivity Index (ASI), and treatment outcome in a sample of 106 subjects with a DSM-III-R diagnosis of panic disorder (with or without agoraphobia) who were participants in an evaluation study of cognitive-behavioral treatment. Results revealed that subjects who received active treatment had significantly lower anxiety sensitivity scores at post-treatment than the wait-list control group. We also examined change in anxiety sensitivity from pre- to post-treatment in reference to Clinical Global Improvement (CGI) ratings and with the effect size statistic. Subjects who showed improvement based on CGI ratings also demonstrated a reduction in anxiety sensitivity. Furthermore, the effect sizes obtained with the ASI were greater in magnitude than those obtained with other widely used anxiety self-report measures. Taken together, the finds supported the use of the Anxiety Sensitivity Index as a treatment outcome measure in panic disorder research.
本研究的目的是在106名被诊断为惊恐障碍(伴或不伴有广场恐惧症)的受试者样本中,考察通过焦虑敏感性指数(ASI)测量的焦虑敏感性变化与治疗结果之间的关系,这些受试者参与了一项认知行为治疗的评估研究。结果显示,接受积极治疗的受试者在治疗后焦虑敏感性得分显著低于等待名单对照组。我们还参照临床总体改善(CGI)评分并使用效应量统计方法,考察了治疗前到治疗后焦虑敏感性的变化。基于CGI评分显示有改善的受试者,其焦虑敏感性也有所降低。此外,ASI获得的效应量在幅度上大于其他广泛使用的焦虑自评量表获得的效应量。综合来看,这些发现支持将焦虑敏感性指数用作惊恐障碍研究中的治疗结果测量指标。